BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20367030)

  • 1. Insulin nanoparticles for transdermal delivery: preparation and physicochemical characterization and in vitro evaluation.
    Zhao X; Zu Y; Zu S; Wang D; Zhang Y; Zu B
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1177-85. PubMed ID: 20367030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
    Patil NH; Devarajan PV
    Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of chitosan-polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin.
    Zu Y; Zhang Y; Zhao X; Shan C; Zu S; Wang K; Li Y; Ge Y
    Int J Biol Macromol; 2012 Jan; 50(1):82-7. PubMed ID: 22020189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.
    Zhao X; Zu Y; Jiang R; Wang Y; Li Y; Li Q; Zhao D; Zu B; Zhang B; Sun Z; Zhang X
    Int J Mol Sci; 2011; 12(4):2678-91. PubMed ID: 21731466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
    Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
    Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
    Rastogi R; Anand S; Koul V
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
    Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
    Cui FD; Tao AJ; Cun DM; Zhang LQ; Shi K
    J Pharm Sci; 2007 Feb; 96(2):421-7. PubMed ID: 17051590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of insulin microspheres containing protease inhibitor.
    Jelvehgari M; Milani PZ; Siahi-Shadbad MR; Monajjemzadeh F; Nokhodchi A; Azari Z; Valizadeh H
    Arzneimittelforschung; 2011; 61(1):14-22. PubMed ID: 21355442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
    Cui F; Shi K; Zhang L; Tao A; Kawashima Y
    J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymethacrylate based microparticulates of insulin for oral delivery, part II: solid state characterization.
    Agarwal V; Khan MA; Nazzal S
    Pharmazie; 2008 Feb; 63(2):122-8. PubMed ID: 18380398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Tort S; Mutlu Agardan NB; Han D; Steckl AJ
    J Microencapsul; 2020 Nov; 37(7):517-527. PubMed ID: 32783663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.